Are critical care authors publication dealers?
An unfeasibly large number of publications in recognized, peer-reviewed journals might reveal guest authorship, or some kind of fraud [1, 2]. Ioannidis et al. recently reported that some scientists were indeed disproportionably hyperprolific . Although asserting that they have no evidence of any fraud, Ioannidis et al., however, suggested that these authors may “have operationalized their own definitions of what authorship means” by not fulfilling several criteria established for the authorship of medical studies. The aim of our study was therefore to investigate the perception of both authorship and conflicts of interest among the most prolific authors in critical care. These prolific authors were identified by searching Pubmed for original articles, conference papers, reviews, editorials, opinion articles, and letters, published in journals with an Impact Factor of 2017 > 5 in the Web of Science category CRITICAL CARE MEDICINE (ESM 1) between the 1 June 2013 and the...
Compliance with ethical standards
Conflicts of interest
A De Jong reports personal fees from Baxter and Medtronic-Covidien, and travel reimbursements from Fresenius-Kabi, MSD France, Astellas, Pfizer and Fisher Paykel. J. Helms reports congress and travel reimbursements from Pfizer, Diagnostica Stago, MSD France, Astrazeneca and Gilead Sciences. E. Weiss reports personal fees form Baxter, MSD France and Biomerieux, and travel reimbursements from MSD France and Eumedica. The other authors have no conflict of interest to declare.